Reasons for ineligibility for a randomized clinical trial

Journal of Health Care for the Poor and Underserved

Volumn 14, Issue 3, 2003, Pages 324-330

  Jean, Samuel ^a   Richter, Kimber P ^a   Ahluwalia, Jasjit S ^a   Schmelzle, Kristin H ^b   Mayo, Matthew S ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b PRA International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGANIZATION AND MANAGEMENT; OUTPATIENT; PATIENT REFERRAL; PREGNANT WOMAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; TELEPHONE; TRANSDERMAL PATCH; VIDEOTAPE; HEALTH SERVICES RESEARCH; LETTER; PATIENT SELECTION; STATISTICS; UNITED STATES;

ELIGIBILITY DETERMINATION; HEALTH SERVICES RESEARCH; HUMANS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 0141594763     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.2010.0539     Document Type: Article

References (11)

1. Ahluwalia JS, Richter KP, Mayo MS, et al. Quit for Life: A randomized trial of culturally sensitive materials for smoking cessation in African Americans. J Gen Intern Med 1999 Apr;14(Suppl 2):6.
2. United States Department of Health and Human Services. Healthy People 2000: Midcourse review and 1995 revisions. Washington, DC: Government Printing Office, 1995. (DHHS Pub. No. (PHS) 91-50213.)
3. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: Toward a participant-friendly system. J Natl Cancer Inst 1995 Dec 6;87(23):1747-59.
4. McCarthy CR. Historical background of clinical trials involving women and minorities. Acad Med 1994 Sep;69(9):695-98.
5. LaRue LJ, Alter M, Traven ND, et al. Acute stroke therapy trials: Problems in patient accrual. Stroke 1988 Aug;19(8):950-54.
6. SAS Institute Inc. SAS user's guide: Statistics. 6th ed. Cary, NC: SAS Institute, 1990.
7. Silagy C, Mant D, Fowler G, et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994 Jan 15;343(8890):139-42.
8. Daughton D, Susman J, Sitorius M, et al. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group. Arch Fam Med. 1998 Sep-Oct;7(5):425-30.
9. Westman EC, Levin ED, Rose JE. The nicotine patch in smoking cessation. A randomized trial with telephone counseling. Arch Intern Med 1993 Aug 23;153(16):1917-23.
10. Caraballo RS, Giovino GA, Pechacek TF, et al. Racial and ethnic differences in serum continine levels of adult cigarette smokers, Third National Health and Nutrition Examination Survey, 1988-1991. JAMA 1998 Jul 8;280(2):135-59.
11. Jolicoeur DG, Ahluwalia JS, Richter KP, et al. The use of nicotine patches with minimal intervention. Prev Med 2000 Jun;30(6):504-12.